Seattle Biotech Raises $3.5 Million to Pursue Alzheimer's, Other Brain Disease Drugs
from Piget Sound Business Journal
A young Seattle biotech company is raising funds to push forward its work on developing brain disease treatments. M3 Biotechnology, founded in 2011 at Washington State University and now based at the University of Washington's CoMotion commercialization center, just raised $3.5 million in equity investments. That money is part of M3's series A funding round. M3 Biotechnology is aiming to raise a total of $8 million.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063